Experience and perpetration of intimate partner violence and abuse by gender of respondent and their current partner before and during COVID-19 restrictions in 2020: a cross-sectional study in 13 countries

被引:14
作者
Gilchrist, Gail [1 ]
Potts, Laura C. [2 ]
Connolly, Dean J. [1 ,3 ]
Winstock, Adam [4 ,5 ]
Barratt, Monica J. [6 ,7 ,8 ]
Ferris, Jason [9 ]
Gilchrist, Elizabeth [10 ]
Davies, Emma
机构
[1] Kings Coll London, Inst Psychiat Psychol & Neurosci, Natl Addict Ctr, London, England
[2] Kings Coll London, Inst Psychiat Psychol & Neurosci, Dept Biostat & Hlth Informat, London, England
[3] Whipps Cross Univ Hosp, Barts Hlth NHS Trust, London, England
[4] UCL, Inst Epidemiol & Hlth Care, London, England
[5] Global Drug Survey, London, England
[6] RMIT Univ, Social & Global Studies Ctr, Melbourne, Australia
[7] RMIT Univ, Digital Ethnog Res Ctr, Melbourne, Australia
[8] UNSW Sydney, Natl Drug & Alcohol Res Ctr, Randwick, Australia
[9] Univ Queensland, Fac Med, Ctr Hlth Serv Res, Brisbane, Australia
[10] Oxford Brookes Univ, Fac Hlth & Life Sci, Ctr Psychol Res, Oxford, England
关键词
Intimate partner violence and abuse; COVID-19; Gender and sexual minorities; Non-binary; LGBTQI plus; Transgender; DOMESTIC VIOLENCE; RISK-FACTORS; SEX; HEALTH; PREVALENCE; MEN; TRANSGENDER; PREDICTORS; ALCOHOL; MISUSE;
D O I
10.1186/s12889-022-14635-2
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
BackgroundIntimate partner violence and abuse (IPVA) includes controlling behaviours, psychological, physical, sexual and financial abuse. Globally, surveys and emergency services have recorded an increase in IPVA since restrictions were imposed to limit COVID-19 transmission. Most studies have only included heterosexual women.MethodsData from the Global Drug Survey (an annual, anonymous, online survey collecting data on drug use) Special Edition were analysed to explore the impact of COVID-19 on people's lives, including their intimate relationships. Five relationship groupings were created using respondents' lived gender identity: women partnered with men (46.9%), women partnered with women (2.1%), men partnered with men (2.9%), men partnered with women (47.2%), and partnerships where one or both partners were non-binary (1%). Self-reported experience and perpetration of IPVA in the past 30 days before (February) and during COVID-19 restrictions (May or June) in 2020 (N = 35,854) was described and compared for different relationship groupings using Fishers Exact Tests. Changes in IPVA during restrictions were assessed using multivariable logistic regression.ResultsDuring restrictions, 17.8 and 16.6% of respondents had experienced or perpetrated IPVA respectively; 38.2% of survivors and 37.6% of perpetrators reported this had increased during restrictions. Greater proportions of non-binary respondents or respondents with a non-binary partner reported experiencing or perpetrating IPVA (p < .001) than other relationship groupings. 22.0% of respondents who were non-binary or had a non-binary partner, 19.5% of men partnered with men, 18.9% of men partnered with women, 17.1% of women partnered with women and 16.6% of women partnered with men reported experiencing IPVA. Respondents with higher psychological distress, poor coping with pandemic-related changes, relationship tension and changes (increases or increases and decreases) in alcohol consumption reported increased experience of IPVA during restrictions.ConclusionsThis study confirmed that IPVA can occur in all intimate relationships, regardless of gender of the perpetrator or survivor. Non-binary respondents or respondents with non-binary partners reported the highest use and experience of IPVA. Most IPVA victim support services have been designed for heterosexual, cisgender women. IPVA support services and perpetrator programmes must be tailored to support all perpetrators and survivors during the pandemic and beyond, regardless of their sexual or gender identity.
引用
收藏
页数:19
相关论文
共 106 条
[21]   Power and Inequality: Intimate Partner Violence Against Bisexual and Non-Monosexual Women in the United States [J].
Coston, Bethany M. .
JOURNAL OF INTERPERSONAL VIOLENCE, 2021, 36 (1-2) :381-405
[22]   Associations Between Alcohol Use and Intimate Partner Violence Among Men Who Have Sex with Men [J].
Davis, Alissa ;
Kaighobadi, Farnaz ;
Stephenson, Rob ;
Rael, Christine ;
Sandfort, Theodorus .
LGBT HEALTH, 2016, 3 (06) :400-406
[23]   Prevalence of Physical Violence in Intimate - Relationships, Part 1: Rates of Male and Female Victimization [J].
Desmarais, Sarah L. ;
Reeves, Kim A. ;
Nicholls, Tonia L. ;
Telford, Robin P. ;
Fiebert, Martin S. .
PARTNER ABUSE, 2012, 3 (02) :140-169
[24]   Sexual consent and chemsex: a quantitative study on sexualised drug use and non-consensual sex among men who have sex with men in Amsterdam, the Netherlands [J].
Druckler, Susanne ;
Speulman, Jilke ;
van Rooijen, Martijn ;
De Vries, Henry J. C. .
SEXUALLY TRANSMITTED INFECTIONS, 2021, 97 (04) :268-275
[25]   Prevalence and risk factors of violence against women and children during COVID-19, Germany [J].
Ebert, Cara ;
Steinert, Janina, I .
BULLETIN OF THE WORLD HEALTH ORGANIZATION, 2021, 99 (06) :429-438
[26]   Digital or Digitally Delivered Responses to Domestic and Intimate Partner Violence During COVID-19 [J].
Emezue, Chuka .
JMIR PUBLIC HEALTH AND SURVEILLANCE, 2020, 6 (03) :294-302
[27]   A Pandemic within a Pandemic - Intimate Partner Violence during Covid-19 [J].
Evans, Megan L. ;
Lindauer, Margo ;
Farrell, Maureen E. .
NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (24) :2302-2304
[28]  
Fereidooni R., 2020, SSRN ELECT J, DOI [10.2139/ssrn.3752688, DOI 10.2139/SSRN.3752688]
[29]   Intimate Partner Violence Among Men Who Have Sex With Men: A Systematic Review [J].
Finneran, Catherine ;
Stephenson, Rob .
TRAUMA VIOLENCE & ABUSE, 2013, 14 (02) :168-185
[30]   Sexual Minority Disparities in Health and Well-being as a Consequence of the COVID-19 Pandemic Differ by Sexual Identity [J].
Fish, Jessica N. ;
Salerno, John ;
Williams, Natasha D. ;
Rinderknecht, R. Gordon ;
Drotning, Kelsey J. ;
Sayer, Liana ;
Doan, Long .
LGBT HEALTH, 2021, 8 (04) :263-272